Pharmacokinetically guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients.
Simon E KoeleStijn W van BeekAnthonie J van der WekkenBerber PietMichel M van den HeuvelRob Ter HeinePublished in: British journal of clinical pharmacology (2022)
Keyphrases